Everolimus

Everolimus ATC Code L01EG02 : Antineoplastic and immunomodulating agents - Antineoplastic drugs - Protein kinase inhibitors - Mammalian target of rapamycin (mTOR) kinase inhibitors - Everolimus
Everolimus
RoutesOral
FDA Approval Date2009-03-30
Molecular FormulaC53H83NO14
Molecular Weight958.24 g/mol
CAS Number159351-69-6
Brand namesAfinitor, Zortress


ATC Codes

  1. Alimentary tract and metabolisma
  2. Blood and blood forming organs
  3. Cardiovascular system
  4. Dermatological drugs
  5. Genitourinary system and reproductive hormones
  6. Systemic hormonal preparations
  7. Antiinfectives for systemic use
  8. Antineoplastic and immunomodulating agents
  9. Musculoskeletal system
  10. Nervous system
  11. Antiparasitic products, insecticides and repellents
  12. Respiratory system
  13. Sensory organs
  14. Various ATC structures

The newly added categories

  1. Givosiran
  2. Volanesorsen
  3. Casimersen
  4. Zanubrutinib
  5. Tivozanib
  6. Fedratinib
  7. Tucatinib
  8. Everolimus
  9. Abemaciclib
  10. Selumetinib